Ad is loading...
KALA
Price
$6.70
Change
-$0.06 (-0.89%)
Updated
Nov 15 closing price
UNCY
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Nov 15 closing price
130 days until earnings call
Ad is loading...

KALA vs UNCY

Header iconKALA vs UNCY Comparison
Open Charts KALA vs UNCYBanner chart's image
Kala BIO
Price$6.70
Change-$0.06 (-0.89%)
Volume$9.95K
CapitalizationN/A
Unicycive Therapeutics
Price$0.46
Change+$0.01 (+2.22%)
Volume$1.78M
CapitalizationN/A
KALA vs UNCY Comparison Chart
Loading...
KALA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KALA vs. UNCY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Sell and UNCY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KALA: $6.70 vs. UNCY: $0.46)
Brand notoriety: KALA and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 45% vs. UNCY: 108%
Market capitalization -- KALA: $30.87M vs. UNCY: $43.4M
KALA [@Biotechnology] is valued at $30.87M. UNCY’s [@Biotechnology] market capitalization is $43.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, KALA is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • KALA’s TA Score: 5 bullish, 5 bearish.
  • UNCY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KALA and UNCY are a good buy in the short-term.

Price Growth

KALA (@Biotechnology) experienced а -12.19% price change this week, while UNCY (@Biotechnology) price change was -22.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

KALA is expected to report earnings on May 09, 2023.

UNCY is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UNCY($43.4M) has a higher market cap than KALA($30.9M). KALA YTD gains are higher at: -4.286 vs. UNCY (-46.986). UNCY has higher annual earnings (EBITDA): -22.83M vs. KALA (-32.6M). KALA has more cash in the bank: 54.2M vs. UNCY (41.8M). UNCY has less debt than KALA: UNCY (634K) vs KALA (36.8M). KALA (0) and UNCY (0) have equivalent revenues.
KALAUNCYKALA / UNCY
Capitalization30.9M43.4M71%
EBITDA-32.6M-22.83M143%
Gain YTD-4.286-46.9869%
P/E RatioN/AN/A-
Revenue00-
Total Cash54.2M41.8M130%
Total Debt36.8M634K5,804%
FUNDAMENTALS RATINGS
KALA: Fundamental Ratings
KALA
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALAUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
KALA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ET17.290.14
+0.82%
Energy Transfer LP
RAVE2.78-0.02
-0.71%
Rave Restaurant Group
SPRY14.01-0.10
-0.71%
ARS Pharmaceuticals
JHG44.50-1.16
-2.54%
Janus Henderson Group plc
GCO29.57-1.17
-3.81%
Genesco

KALA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALA has been loosely correlated with ATHE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KALA jumps, then ATHE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-0.89%
ATHE - KALA
36%
Loosely correlated
-5.56%
PALI - KALA
31%
Poorly correlated
-3.82%
ARDX - KALA
28%
Poorly correlated
+5.52%
ENTX - KALA
27%
Poorly correlated
-2.81%
UNCY - KALA
27%
Poorly correlated
+2.68%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with BLPH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then BLPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+2.68%
BLPH - UNCY
35%
Loosely correlated
N/A
BBIO - UNCY
32%
Poorly correlated
-1.62%
SCPX - UNCY
28%
Poorly correlated
-8.61%
SLDB - UNCY
28%
Poorly correlated
-8.66%
MRKR - UNCY
27%
Poorly correlated
-12.29%
More